aeris Capital Equity Investments, L.P. - Net Worth and Insider Trading

aeris Capital Equity Investments, L.P. Net Worth

The estimated net worth of aeris Capital Equity Investments, L.P. is at least $14 Million dollars as of 2024-11-07. aeris Capital Equity Investments, L.P. is the 10% Owner of Adamas Pharmaceuticals Inc and owns about 1,662,128 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $14 Million. Details can be seen in aeris Capital Equity Investments, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that aeris Capital Equity Investments, L.P. has not made any transactions after 2015-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of aeris Capital Equity Investments, L.P.

To

aeris Capital Equity Investments, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, aeris Capital Equity Investments, L.P. owns 1 companies in total, including Adamas Pharmaceuticals Inc (ADMS) .

Click here to see the complete history of aeris Capital Equity Investments, L.P.’s form 4 insider trades.

Insider Ownership Summary of aeris Capital Equity Investments, L.P.

Ticker Comapny Transaction Date Type of Owner
ADMS Adamas Pharmaceuticals Inc 2015-03-13 10 percent owner

aeris Capital Equity Investments, L.P. Latest Holdings Summary

aeris Capital Equity Investments, L.P. currently owns a total of 1 stock. aeris Capital Equity Investments, L.P. owns 1,662,128 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 13, 2015, with a value of $14 Million.

Latest Holdings of aeris Capital Equity Investments, L.P.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADMS Adamas Pharmaceuticals Inc 2015-03-13 1,662,128 8.22 13,662,692

Holding Weightings of aeris Capital Equity Investments, L.P.


aeris Capital Equity Investments, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, aeris Capital Equity Investments, L.P. has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 350,000 shares on March 13, 2015, which brought aeris Capital Equity Investments, L.P. around $6 Million.

Insider Trading History of aeris Capital Equity Investments, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

aeris Capital Equity Investments, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

aeris Capital Equity Investments, L.P. Ownership Network

Ownership Network List of aeris Capital Equity Investments, L.P.

No Data

Ownership Network Relation of aeris Capital Equity Investments, L.P.

Insider Network Chart

aeris Capital Equity Investments, L.P. Owned Company Details

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

aeris Capital Equity Investments, L.P. is the 10 percent owner of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

aeris Capital Equity Investments, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for aeris Capital Equity Investments, L.P.. You might contact aeris Capital Equity Investments, L.P. via mailing address: C/o Avalon Management Ltd, Landmark Sq 1st Floor, P.o. Box 715, 64 Earth Close Grand Cayman E9 Ky1-1107.